Cerevel Therapeutics Holdings Cash from Operations (TTM) Analysis

Cerevel Therapeutics Holdings Inc (CERE)

42.13 +0.23 (+0.55%) USD | NASDAQ | Apr 25, 12:47

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	-342.30M
September 30, 2023	-332.36M
June 30, 2023	-340.13M
March 31, 2023	-320.46M
December 31, 2022	-293.19M
September 30, 2022	-258.45M
June 30, 2022	-221.82M

Date	Value
March 31, 2022	-209.78M
December 31, 2021	-178.55M
September 30, 2021	-167.50M
June 30, 2021	-143.81M
March 31, 2021	-124.77M
December 31, 2020	-117.80M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-342.30M

Minimum

Dec 2023

-117.80M

Maximum

Dec 2020

-234.69M

Average

-221.82M

Median

Jun 2022

Cash from Operations (TTM) Benchmarks